Follow
Christian Steidl
Christian Steidl
Professor, Department of Pathology and Laboratory Medicine, University of British Columbia
Verified email at bccancer.bc.ca
Title
Cited by
Cited by
Year
Tumor-associated macrophages and survival in classic Hodgkin's lymphoma
C Steidl, T Lee, SP Shah, P Farinha, G Han, T Nayar, A Delaney, ...
New England Journal of Medicine 362 (10), 875-885, 2010
14622010
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
SP Shah, RD Morin, J Khattra, L Prentice, T Pugh, A Burleigh, A Delaney, ...
Nature 461 (7265), 809-813, 2009
13182009
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
NA Johnson, GW Slack, KJ Savage, JM Connors, S Ben-Neriah, S Rogic, ...
Journal of clinical oncology 30 (28), 3452, 2012
10972012
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients
D Haase, U Germing, J Schanz, M Pfeilstöcker, T Nösslinger, ...
Blood, The Journal of the American Society of Hematology 110 (13), 4385-4395, 2007
10412007
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international …
J Schanz, H Tüchler, F Solé, M Mallo, E Luño, J Cervera, I Granada, ...
Journal of Clinical Oncology 30 (8), 820, 2012
8362012
Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival
NA Johnson, KJ Savage, O Ludkovski, S Ben-Neriah, R Woods, C Steidl, ...
Blood, The Journal of the American Society of Hematology 114 (11), 2273-2279, 2009
7232009
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
C Steidl, SP Shah, BW Woolcock, L Rui, M Kawahara, P Farinha, ...
Nature 471 (7338), 377-381, 2011
6902011
The International Human Epigenome Consortium: a blueprint for scientific collaboration and discovery
HG Stunnenberg, S Abrignani, D Adams, M de Almeida, L Altucci, V Amin, ...
Cell 167 (5), 1145-1149, 2016
5082016
Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing
RD Morin, K Mungall, E Pleasance, AJ Mungall, R Goya, RD Huff, ...
Blood, The Journal of the American Society of Hematology 122 (7), 1256-1265, 2013
4552013
Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment
C Steidl, JM Connors, RD Gascoyne
Journal of Clinical Oncology 29 (14), 1812-1826, 2011
4472011
Prognostic significance of diffuse large B-cell lymphoma cell of origin determined by digital gene expression in formalin-fixed paraffin-embedded tissue biopsies
DW Scott, A Mottok, D Ennishi, GW Wright, P Farinha, S Ben-Neriah, ...
Journal of clinical oncology 33 (26), 2848, 2015
4392015
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma
R Kridel, B Meissner, S Rogic, M Boyle, A Telenius, B Woolcock, ...
Blood, The Journal of the American Society of Hematology 119 (9), 1963-1971, 2012
4062012
Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma
R Rahal, M Frick, R Romero, JM Korn, R Kridel, F Chun Chan, B Meissner, ...
Nature medicine 20 (1), 87-92, 2014
3942014
Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma
DDW Twa, FC Chan, S Ben-Neriah, BW Woolcock, A Mottok, KL Tan, ...
Blood, The Journal of the American Society of Hematology 123 (13), 2062-2065, 2014
3242014
Double-hit gene expression signature defines a distinct subgroup of germinal center B-cell-like diffuse large B-cell lymphoma
D Ennishi, A Jiang, M Boyle, B Collinge, BM Grande, S Ben-Neriah, ...
Journal of Clinical Oncology 37 (3), 190, 2019
3222019
Cooperative epigenetic modulation by cancer amplicon genes
L Rui, NCT Emre, MJ Kruhlak, HJ Chung, C Steidl, G Slack, GW Wright, ...
Cancer cell 18 (6), 590-605, 2010
3172010
The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia
A Kuendgen, M Schmid, R Schlenk, S Knipp, B Hildebrandt, C Steidl, ...
Cancer 106 (1), 112-119, 2006
2942006
Loss of BAF250a (ARID1A) is frequent in high‐grade endometrial carcinomas
KC Wiegand, AF Lee, OM Al‐Agha, C Chow, SE Kalloger, DW Scott, ...
The Journal of pathology 224 (3), 328-333, 2011
2732011
Probabilistic cell-type assignment of single-cell RNA-seq for tumor microenvironment profiling
AW Zhang, C O’Flanagan, EA Chavez, JLP Lim, N Ceglia, A McPherson, ...
Nature methods 16 (10), 1007-1015, 2019
2712019
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations
B Will, L Zhou, TO Vogler, S Ben-Neriah, C Schinke, R Tamari, Y Yu, ...
Blood, The Journal of the American Society of Hematology 120 (10), 2076-2086, 2012
2532012
The system can't perform the operation now. Try again later.
Articles 1–20